Mariane Tami Amano

Mariane Tami Amano

Auto-generated profile, based on publicly available information

Mariane Tami Amano

Laboratory of Transplantation Immunobiology, Department of Immunology, Institute of Biomedical Sciences IV, University of São Paulo, São Paulo, Brazil

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2015 in Journal of the American Society of Nephrology
Verified
Journal Article
Open access
PDF file
VAVinicius Andrade-Oliveira
Vinicius Andrade-Oliveira
MAMariane T. Amano
Mariane T. Amano
MCMatheus Correa-Costa
Matheus Correa-Costa
ACAngela Castoli
Angela Castoli
RFRaphael Jose Ferreira Felizardo
Raphael Jose Ferreira Felizardo
NCNiels Olsen Saraiva Camara
Niels Olsen Saraiva Camara
Short-chain fatty acids (SCFAs) are fermentation end products produced by the intestinal microbiota and have anti-inflammatory and histone deacetylase–inhibiting properties. Recently, a dual relationship between the intestine and kidneys has been unraveled. Therefore, we evaluated the role of SCFA in an AKI model in which the inflammatory process has a detrimental role. We observed that therapy with the three main SCFAs (acetate, propionate, and butyrate) improved renal dysfunction caused by injury. This protection was associated with low levels of local and systemic inflammation, oxidative cellular stress, cell infiltration/activation, and apoptosis. However, it was also associated with an increase in autophagy. Moreover, SCFAs inhibited histone deacetylase activity and modulated the expression levels of enzymes involved in chromatin modification. In vitro analyses showed that SCFAs modulated the inflammatory process, decreasing the maturation of dendritic cells and inhibiting the capacity of these cells to induce CD4+ and CD8+ T cell proliferation. Furthermore, SCFAs ameliorated the effects of hypoxia in kidney epithelial cells by improving mitochondrial biogenesis. Notably, mice treated with acetate-producing bacteria also had better outcomes after AKI. Thus, we demonstrate that SCFAs improve organ function and viability after an injury through modulation of the inflammatory process, most likely via epigenetic modification.

20 August 2018 in Nature Immunology
Verified
Journal Article
Open access
PDF file
SCSergi Cuartero
Sergi Cuartero
FWFelix D. Weiss
Felix D. Weiss
GDGopuraja Dharmalingam
Gopuraja Dharmalingam
YGYa Guo
Ya Guo
EIElizabeth Ing-Simmons
Elizabeth Ing-Simmons
MMMatthias Merkenschlager
Matthias Merkenschlager
Cohesin is important for 3D genome organization. Nevertheless, even the complete removal of cohesin has surprisingly little impact on steady-state gene transcription and enhancer activity. Here we show that cohesin is required for the core transcriptional response of primary macrophages to microbial signals, and for inducible enhancer activity that underpins inflammatory gene expression. Consistent with a role for inflammatory signals in promoting myeloid differentiation of hematopoietic stem and progenitor cells (HPSCs), cohesin mutations in HSPCs led to reduced inflammatory gene expression and increased resistance to differentiation-inducing inflammatory stimuli. These findings uncover an unexpected dependence of inducible gene expression on cohesin, link cohesin with myeloid differentiation, and may help explain the prevalence of cohesin mutations in human acute myeloid leukemia.

11 September 2018 in Frontiers in Immunology
Verified
Journal Article
Open access
AJAlessander Leyendecker Jr.
Alessander Leyendecker Jr.
CPCarla C. G. Pinheiro
Carla C. G. Pinheiro
MAMariane Tami Amano
Mariane Tami Amano
Daniela Franco BuenoDaniela Franco Bueno
Daniela Franco Bueno
Background: One of the greatest challenges for medicine is to find a safe and effective treatment for immune-related diseases. However, due to the low efficacy of the treatment available and the occurrence of serious adverse effects, many groups are currently searching for alternatives to the traditional therapy. In this regard, the use of human mesenchymal stem cells (hMSCs) represents a great promise for the treatment of a variety of immune-related diseases due to their potent immunomodulatory properties. The main objective of this study is, therefore, to present and summarize, through a systematic review of the literature, in vivo studies in which the efficacy of the administration of hMSCs for the treatment of immune-related diseases was evaluated. Methods: The article search was conducted in PubMed/MEDLINE, Scopus and Web of Science databases. Original research articles assessing the therapeutic potential of hMSCs administration for the in vivo treatment immune-related diseases, published from 1984 to December 2017, were selected and evaluated. Results: A total of 132 manuscripts formed the basis of this systematic review. Most of the studies analyzed reported positive results after hMSCs administration. Clinical effects commonly observed include an increase in the survival rates and a reduction in the severity and incidence of the immune-related diseases studied. In addition, hMSCs administration resulted in an inhibition in the proliferation and activation of CD19+ B cells, CD4+ Th1 and Th17 cells, CD8+ T cells, NK cells, macrophages, monocytes and neutrophils. The clonal expansion of both Bregs and Tregs cells, however, was stimulated. Administration of hMSCs also resulted in a reduction in the levels of pro-inflammatory cytokines such as IFN-γ, TNF-α, IL-1, IL-2, IL-12 and IL-17 and in an increase in the levels of immunoregulatory cytokines such as IL-4, IL-10 and IL-13. Conclusions: The results obtained in this study open new avenues for the treatment of immune-related diseases through the administration of hMSCs and emphasize the importance of the conduction of further studies in this area.

31 July 2017 in Frontiers in Immunology
Verified
Journal Article
Open access
JAJuan S. Henao Agudelo
Juan S. Henao Agudelo
TBTarcio T. Braga
Tarcio T. Braga
MAMariane T. Amano
Mariane T. Amano
MCMarcos A. Cenedeze
Marcos A. Cenedeze
RCRegiane A. Cavinato
Regiane A. Cavinato
NCNiels Olsen Saraiva Camara
Niels Olsen Saraiva Camara
Mesenchymal stromal cells (MSCs) are multipotent cells with abilities to exert immunosuppressive response promoting tissue repair. Studies have shown that MSCs can secrete extracellular vesicles (MVs-MSCs) with similar regulatory functions to the parental cells. Furthermore, strong evidence suggesting that MVs-MSCs can modulate several immune cells (i.e. Th1, Th17 and Foxp3+ T cells). However, their precise effect on macrophages (Mɸs) remains unexplored. We investigated the immunoregulatory effect of MVs-MSCs on activated M1-Mɸs in vitro and in vivo using differentiated bone marrow Mɸs and an acute experimental model of thioglycollate-induced peritonitis, respectively. We observed that MVs-MSCs shared surface molecules with MSCs (CD44, CD105, CD90, CD73) and expressed classical microvesicle markers (Annexin V and CD9). The in vitro treatment with MVs-MSCs exerted a regulatory-like phenotype in M1-Mɸs, which showed higher CD206 level and reduced CCR7 expression. This was associated with decreased levels of inflammatory molecules (IL-1β, IL-6, NO) and increased immunoregulatory markers (IL-10 and Arginase) in M1-Mɸs. In addition, we detected that MVs-MSCs promoted the down-regulation of inflammatory miRNAs (miR-155 and miR-21), as well as its predicted target gene SOCS3 in activated M1-Mɸs. In vivo MVs-MSCs treatment reduced the Mɸs infiltrate in the peritoneal cavity inducing a M2-like regulatory phenotype in peritoneal Mɸs (higher arginase activity and reduced expression of CD86, iNOS, IFN-γ, IL-1β, TNF-α, IL-1α and IL-6 molecules). This in vivo immunomodulatory effect of MVs-MSCs on M1-Mɸs was partially associated with the up-regulation of CX3CR1 in F4/80+/Ly6C+/CCR2+ Mɸs subsets. In summary, our findings indicate that MVs-MSCs can modulate an internal program in activated Mɸs establishing an alternative regulatory-like phenotype.

14 November 2012 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MCMatheus Correa-Costa
Matheus Correa-Costa
HAHátylas Azevedo
Hátylas Azevedo
MAMariane Tami Amano
Mariane Tami Amano
GGGiselle Martins Gonçalves
Giselle Martins Gonçalves
MHMeire Ioshie Hyane
Meire Ioshie Hyane
NCNiels Olsen Saraiva Camara
Niels Olsen Saraiva Camara
Ischemia/reperfusion injury (IRI) is a leading cause of acute renal failure. The definition of the molecular mechanisms involved in renal IRI and counter protection promoted by ischemic pre-conditioning (IPC) or Hemin treatment is an important milestone that needs to be accomplished in this research area. We examined, through an oligonucleotide microarray protocol, the renal differential transcriptome profiles of mice submitted to IRI, IPC and Hemin treatment. After identifying the profiles of differentially expressed genes observed for each comparison, we carried out functional enrichment analysis to reveal transcripts putatively involved in potential relevant biological processes and signaling pathways. The most relevant processes found in these comparisons were stress, apoptosis, cell differentiation, angiogenesis, focal adhesion, ECM-receptor interaction, ion transport, angiogenesis, mitosis and cell cycle, inflammatory response, olfactory transduction and regulation of actin cytoskeleton. In addition, the most important overrepresented pathways were MAPK, ErbB, JAK/STAT, Toll and Nod like receptors, Angiotensin II, Arachidonic acid metabolism, Wnt and coagulation cascade. Also, new insights were gained about the underlying protection mechanisms against renal IRI promoted by IPC and Hemin treatment. Venn diagram analysis allowed us to uncover common and exclusively differentially expressed genes between these two protective maneuvers, underscoring potential common and exclusive biological functions regulated in each case. In summary, IPC exclusively regulated the expression of genes belonging to stress, protein modification and apoptosis, highlighting the role of IPC in controlling exacerbated stress response. Treatment with the Hmox1 inducer Hemin, in turn, exclusively regulated the expression of genes associated with cell differentiation, metabolic pathways, cell cycle, mitosis, development, regulation of actin cytoskeleton and arachidonic acid metabolism, suggesting a pleiotropic effect for Hemin. These findings improve the biological understanding of how the kidney behaves after IRI. They also illustrate some possible underlying molecular mechanisms involved in kidney protection observed with IPC or Hemin treatment maneuvers.

1 October 2014 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MMMariana Yasue Saito Miyagi
Mariana Yasue Saito Miyagi
MSMarilia Seelaender
Marilia Seelaender
ACAngela Castoli
Angela Castoli
DADanilo Candido De Almeida
Danilo Candido De Almeida
ABAline Villa Nova Bacurau
Aline Villa Nova Bacurau
MAMariane Tami Amano
Mariane Tami Amano
Nephrotoxicity is substantial side effect for 30% of patients undergoing cancer therapy with cisplatin and may force them to change or even abandon the treatment. Studies regarding aerobic exercise have shown its efficacy for the treatment of many types of diseases and its capacity to reduce tumors. However, little is known about the impact of physical exercise on cisplatin-induced acute kidney injury (AKI). In the present study, our aim was to investigate the role of physical exercise in AKI induced by cisplatin. We submitted C57Bl6 male mice to seven weeks of chronic exercise on a training treadmill and treated them with single i.p. injection of cisplatin (20 mg/kg) in the last week. Exercise efficacy was confirmed by an increased capillary-to-fiber ratio in the gastrocnemius muscle of exercised groups (EX and CIS-EX). The group submitted to exercise before cisplatin administration (CIS-EX) exhibited less weight loss and decreased serum urea levels compared to the cisplatin group (CIS). Exercise also showed a protective role against cisplatin-induced cell death in the kidney. The CIS-EX group showed a lower inflammatory response, with less TNF and IL-10 expression in the kidney and serum. In the same group, we observed an increase of IL-6 and HO-1 expression in the kidney. Taken together, our results indicate that chronic aerobic exercise is able to attenuate AKI by inducing IL-6 and HO-1 production, which results in lower inflammatory and apoptotic profiles in the kidney.